Connect with us

Technology

Flockscreen LAMP Avian Influenza Test for Poultry First Rapid Molecular Test to Accurately Detect the Presence of Virus in Both Cloacal and Oropharyngeal Samples

Published

on

Alveo Technologies developed this groundbreaking product in partnership with x-Ovo, Royal GD and Pharmsure; first shipments of Flockscreen to EMEA expected Q3 2024

ALAMEDA, Calif., June 27, 2024 /PRNewswire/ — Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced that rigorous development and testing has demonstrated that the Flockscreen LAMP Avian Influenza Molecular Test can accurately detect the presence of virus in both cloacal and oropharyngeal samples from poultry with comparable limit of detection, sensitivity and specificity. Alveo and their development partners performed more than 20,000 reactions on over 4000 assay cartridges during their evaluation of over 100 candidate primer sets and assay conditions, using both contrived and clinical samples. Relevant regulatory bodies have been engaged and appropriate validation and verification activities will be completed prior to shipment.

The product is available today for pre-sale in Europe and the Middle East. The company expects to begin shipping in volume in the third quarter of 2024.

The current HPAI panzootic has recently spread to cattle and at least 47 other mammalian species. Due to current disease control legislation, this has led to the destruction of more than half a billion poultry worldwide. Rapid, accurate tests are vital for early detection and containment, protection of the poultry industry, the prevention of zoonotic transmission and spillover events from one species to another, food security, the maintenance of agricultural trade, and ongoing monitoring and surveillance.

Current agricultural tests for highly pathogenic avian influenza (HPAI) all suffer from one of several significant drawbacks that make them unsuited to these use cases. Polymerase chain reaction (PCR) requires lab processing, which means it can take days to receive a result, and vaccination causes serology tests to turn positive even if the bird is not infected1. Lateral flow (also known as antigen or instant tests) lacks sensitivity and produces a significant percentage of false negative results.

Alveo’s portable and rugged molecular diagnostic platform has been designed to provide accurate, rapid test results at the point of need. It functions as a core component of a notifiable disease electronic management ecosystem that the company and its strategic partners have developed to support producers, as well as governmental bodies who are looking to expand the surveillance of important zoonotic pathogens. Two multiplexed panels enable the on-site broad detection of Avian Influenza Type A virus (targeting matrix gene) in poultry with differentiation of H5, H7, and H9 subtypes using oropharyngeal or cloacal samples. Both panels contain 7 assays, 6 of which are identical between cartridges. This configuration ensures the greatest coverage of the most clinically relevant global AI strains from the past 5-10 years, through to the current strains. The platform’s rugged design enables it to function in the field under extreme conditions, including very hot and near freezing temperatures, following a drop of one meter, and when subjected to movement and vibration, which are common challenges encountered in field settings. 

Alveo has developed assays for Flockscreen LAMP AI on its proprietary molecular platform with several partners —including x-OvO, Royal GD, and Pharmsure International Ltd. — and it will provide healthcare and government authorities with a rapid, decentralized, molecular test that eliminates the need to ship hazardous samples to a lab. Additionally, the platform has the capability to wirelessly upload time-stamped geotagged results to a common portal, providing organizations with near real-time information on the spread of the virus. The platform will provide veterinarians with intuitive, rapid, point-of-need testing. For producers, Flockscreen will empower rapid responses to reduce the disease’s spread and mitigate the impact on their business.

“The creation of a decentralized testing ecosystem that respects and expands process control by disease management authorities, combined with molecular biology levels of accuracy, could lead a paradigm shift in the way notifiable disease challenges are controlled,” said Dr. Richard Currie, President, x-OvO.

“Alveo’s molecular diagnostic platform is a groundbreaking technology that raises the bar for speed and accuracy in point-of-need diagnostic testing,” said Wim Kieftenbeld, Director Business Development at Royal GD. “Combined with our expertise in veterinary diseases and diagnostics, we’ve worked together to develop an assay that accurately and rapidly delivers results at point of need for both cloacal and oropharyngeal samples, a first for agricultural diagnostics for HPAI.”

“Our platform makes it simple to test for HPAI in poultry, and we will be the first diagnostic of its kind that can test both cloacal and oropharyngeal samples,” said Shaun Holt, CEO at Alveo. “Our rugged design enables healthcare providers, veterinarians, growers, and public health officials to obtain rapid results at point of need so they can take immediate action.”

Alveo expects first customer shipments of Flockscreen LAMP AI in EMEA to begin by Q3 2024. For more information visit: alveotechnologies.com/flockscreen

About Alveo 
Alveo is the first company to make molecular detection and diagnostics universally accessible – on the farm, in the field, in the clinic, or in the manufacturing plant – helping prevent or significantly limit the destructive impact of viruses, fungi, bacteria, and other pathogens by detecting earlier at the Point of Need™. Alveo’s rugged and portable, multiplex-capable diagnostic platform employs a patented method of direct electrical sensing of nucleic acid amplification to provide affordable, rapid, and accurate results. By enabling early pathogen detection, Alveo helps manage global health, food security, and supply chain resiliency by providing actionable insights at lightspeed. Know Sooner, Act Faster™ with Alveo. For more, visit: https://www.alveotechnologies.com/.

1 Tumpey TM, Alvarez R, Swayne DE, Suarez DL. Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus. J Clin Microbiol. 2005 Feb;43(2):676-83. doi: 10.1128/JCM.43.2.676-683.2005. PMID: 15695663; PMCID: PMC548100.

Media contact
Jeff Miller
jeff@marketstreetgrp.com
541-207-6413

View original content to download multimedia:https://www.prnewswire.com/news-releases/flockscreen-lamp-avian-influenza-test-for-poultry-first-rapid-molecular-test-to-accurately-detect-the-presence-of-virus-in-both-cloacal-and-oropharyngeal-samples-302183714.html

SOURCE Alveo Technologies

Continue Reading

Technology

Visier Debuts Talent Agents, Closing the Gap Between HR Programs and Business Impact

Published

on

By

New AI agents turn Visier insights and plans into guided action for every manager, fixing the #1 reason HR programs fail: manager follow-through

VANCOUVER, BC, Oct. 21, 2026 /PRNewswire/ — Visier today announced Talent Agents at HR Tech 2026. Built on the Visier Workforce Intelligence Platform, these new AI agents guides every manager to the next right action in their organization’s HR programs in real time, and give talent leaders evidence of what each program actually changed for the business.

Talent management devotes a great deal of money and effort into HR programs every year, and many still can’t show the ROI or outcomes. New Visier research* found:

62% of HR leaders name manager follow-through as the single biggest reason programs fail77% of enterprises run HR programs on spreadsheets or a patchwork of tools, and are three times less likely to measure results while a program is underway.

Visier Talent Agents are built to close these gaps, helping talent management tackle its most critical challenges as organizations plan, grow and retain their talent. They leverage the latest in AI developments to pair best-in-class program frameworks with personalized, in-workflow guidance delivered to whoever needs to act next, and a closed-loop system for continuous learning and improvement based on every program’s goals.

“Good program design has never been enough. What HR has lacked is a GPS for every manager, so the moment someone drifts off track, they’re guided back before the program goes sideways,” said Dave Weisbeck, Chief Strategy Officer at Visier. “That’s what Talent Agents deliver, along with proof of what the program actually changed for the business.” 

“The space between HR program design and the actual business result is exactly where most HR investment gets lost,” said Madeline Laurano, founder of Aptitude Research. “Guidance that activates the manager at the moment they need to act, with proof of what changed afterward, is the piece of talent management that’s been missing and what Visier is solving for.”

Unlike HCM suites that teams would spend a year customizing, or point solutions that only see one piece of the picture, or even an internal-built tool that puts employee data at risk, Visier’s Talent Agents are built to run programs end-to-end and prove impact, not just track activity.

The agents reach every stakeholder in a program at the moment they need to act, not just when someone remembers to ask. They’re built to match how an organization actually operates, and the outcome of every action it recommends feeds back into the AI learning engine, so guidance gets sharper with each cycle. Because guidance runs on Visier’s proprietary Workforce AI rather than routing every follow-up through a person, organizations can scale their programs without being constrained by HRBP headcount.

The agents are built on Visier’s Workforce Intelligence Platform, so every program comes with the context, governance, and security an enterprise expects, backed by over 16 years of experience solving HR’s toughest problems.

Talent Agents are Visier’s answer to what the company calls the “activate” layer of Workforce AI, building on the platform’s existing strength in helping organizations understand their workforce data and plan around it. The offering pairs Visier’s technology with a dedicated implementation team that customizes each program to a customer’s specific processes and goals.

Attending HRTech 2026 in Las Vegas this week? Head over to Visier Booth #5209 to explore Talent Agents, or visit visier.com to learn more. The Visier team will also be at UNLEASH World in Paris (booth #106) and Total Talent Asia (booth #3).

About Visier
Visier Workforce AI is the context foundation for talent management. The Visier Workforce Intelligence Platform turns scattered, sensitive people data into one governed understanding of the entire workforce, so organizations can understand, plan, and activate all of their talent priorities in one place. More than 85,000 of the world’s most complex organizations, including Ford Motor Company, eBay, Experian, and Domino’s Pizza, rely on Visier’s over 16 years of workforce domain expertise, ranked #1 in vendor satisfaction and user experience for three consecutive years by the Sapient Insights HR Systems Survey. Learn more at Visier.com.

*Research from fall 2026, conducted by the Visier, Inc. Research Team surveyed verified senior HR and Talent leaders from 80 organizations with more than 10,000 employees across North America.  

visierpr@walkersands.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/visier-debuts-talent-agents-closing-the-gap-between-hr-programs-and-business-impact-302915328.html

SOURCE Visier

Continue Reading

Technology

HSG Laser Unveils New Flagship Machine at EuroBLECH 2026, Powering Productivity for European Manufacturers

Published

on

By

HANNOVER, Germany, Oct. 21, 2026 /PRNewswire/ — HSG Laser is showcasing its latest laser cutting and intelligent manufacturing solutions at EuroBLECH 2026, held from October 20–23 at the Hannover Exhibition Centre. Under the theme “Powering Productivity with HSG,” HSG is presenting its latest innovations at Booth 15-F42, including the European debut of its new flagship GV, alongside the launch of GFA PRO and AI CutPilot, as well as the European debut of its high-speed laser solutions G3015T and R2 PRO.

Expanding High-Performance Laser Solutions

The new GFA PRO is engineered for large-format metal processing, addressing challenges such as large footprints, low speed, unstable thick-plate performance, and high operating costs. Making their European debut, the G3015T and R2 PRO expand HSG’s high-speed laser lineup for sheet and tube processing, helping manufacturers improve throughput, flexibility, and production efficiency.

“HSG Laser’s European footprint has grown steadily, with more than 2,000 units delivered and a new showroom opening soon this year,” said Shawn Wang, Vice President of HSG Laser. “Our latest launches at EuroBLECH mark another step forward, combining high-performance equipment with intelligent technologies and localized support to deliver greater productivity for European customers.”

Recognized by MM MaschinenMarkt Germany

Built for the European market, HSG Laser earned the “International Spotlight” award from MM MaschinenMarkt Germany’s Chief Editor for its GV and AI CutPilot. The GV combines cutting, beveling, countersinking, and chamfering in one machine to streamline pre-welding workflows and boost efficiency. AI CutPilot is HSG’s industry-first, self-developed AI system that turns laser-cutting expertise into a reusable, scalable machine capability, helping reduce trial work and improve first-pass yield. The award further highlights HSG Laser’s technological strength and growing presence in the European market.

Strengthening Local Operations in Europe

As part of its continued commitment to supporting manufacturers worldwide, HSG Laser is further strengthening its localized operations in Europe. On 10th November, HSG will open its new showroom in Düsseldorf, Germany under the theme “Go Global, Link Local.” The new showroom will bring HSG’s latest machines, technologies, and expertise closer to European customers, creating more opportunities for direct engagement and local support. This expansion further strengthens HSG’s presence in Europe and its ability to provide responsive, customer-focused solutions tailored to local manufacturing needs.

About HSG Laser

Founded in 2006, HSG Laser is a leading global manufacturer of intelligent metal processing equipment, specializing in laser cutting, tube processing, bending, and welding automation systems. With a presence in over 100 countries and regional centers across Europe, North America, Japan, India, and Asia-Pacific, HSG Laser is committed to driving the transformation of manufacturing through innovation, reliability, and artificial intelligence.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hsg-laser-unveils-new-flagship-machine-at-euroblech-2026-powering-productivity-for-european-manufacturers-302915275.html

Continue Reading

Technology

Mérieux NutriSciences Completes Acquisition of Certified Group, Becoming North America’s Leading Food Testing Provider

Published

on

By

CHICAGO, Oct. 21, 2026 /PRNewswire/ — Mérieux NutriSciences, a global leader in food safety, quality, and sustainability, today announced the successful completion of its acquisition of Certified Group.

First announced in August 2026, this strategic transaction unites two complementary leaders in the Testing, Inspection, and Certification (TIC) sector. With approximately $300 million in revenue, Certified Group brings 31 laboratories and over 1,600 talented employees into Mérieux NutriSciences’ global network. The integration also adds a robust roster of more than 170 independent regulatory consultants across the United States and Canada.

With this expanded coast-to-coast footprint, Mérieux NutriSciences is positioned to provide customers with broader service offerings and enhanced regulatory support. The integration deepens the company’s capabilities in key Food & Beverage segments, most notably in animal protein through its Food Safety Net Services (FSNS) network, where Certified Group has built a strong reputation as a bellwether for safety and quality, alongside leading positions in dairy, packaged foods, nuts, and spices.

Customers will also benefit from high-value expertise in cosmetics, OTC products, and dietary supplements through the Certified Laboratories vertical, and reduced-harm nicotine product testing via Labstat International. These core verticals are further bolstered by specialized expert services, including contract research (Lab Plus), regulatory consulting (EAS Consulting Group), and comprehensive certification and audit programs (FSNS Certification and Audit).

“We are thrilled to officially welcome the talented teams from Certified Group to the Mérieux NutriSciences global network,” said Nicolas Cartier, CEO of Mérieux NutriSciences. “By combining our respective strengths, we are vastly expanding the depth and breadth of our capabilities. This milestone allows us to be closer to our customers, meeting their localized, time-sensitive needs with unmatched speed and reliability, while furthering our shared purpose: Better Food. Better Health. Better World.”

“Our priority is to ensure a seamless transition for all customers while delivering immediate, enhanced value,” added Sébastien Moulard, President North America at Mérieux NutriSciences. “Through this nationwide analytical network, customers now have access to a truly comprehensive portfolio of routine testing, specialized analysis, expert regulatory support, and more. We are excited to leverage the best of both worlds to drive innovation and provide practical solutions right where production happens.”

“Certified Group has built a differentiated platform with a strong reputation for quality, scientific excellence and exceptional customer service,” said Deborah Kerr, Managing Director, Warburg Pincus & Executive Chair, Certified Group. “We are proud to have supported Certified Group’s evolution and look forward to seeing the company continue to thrive as part of Mérieux NutriSciences.”

The financing of the acquisition brings new minority shareholders Peugeot Invest and Continental Grain Company (Conti) alongside Mérieux NutriSciences’ long standing shareholders: Institut Mérieux, Sofina, and Dassault Group. This collective support underscores strong market confidence in the company’s strategic vision. Ultimately, the successful integration of Certified Group solidifies Mérieux NutriSciences as the leading provider in North America and a top player in the global food TIC market, further cementing its role as the trusted partner for customers navigating a rapidly evolving landscape.

About Mérieux NutriSciences:

At Mérieux NutriSciences, we leverage 60 years of scientific and entrepreneurial expertise to answer food industry needs. Today’s global challenges transform the way food is produced, marketed and consumed, which is why we know our clients need more than reliable analytical results; they need practical and innovative solutions that will contribute to make food systems safer, healthier and more sustainable. Present worldwide, we are more than 160 accredited laboratories and a team of over 11,600 committed employees. We strongly believe that together, we can create solutions to offer our planet: BETTER FOOD. BETTER HEALTH. BETTER WORLD. na.mxns.com

MERIEUX NUTRISCIENCES
Stephen Nichols (North America)
stephen.nichols@mxns.com 

Marion Bertrand (Global)
media@mxns.com 

Ashton van den Bergh (Global)
media@mxns.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/merieux-nutrisciences-completes-acquisition-of-certified-group-becoming-north-americas-leading-food-testing-provider-302915607.html

SOURCE Mérieux NutriSciences

Continue Reading

Trending